ClinicalTrials.Veeva

Find clinical trials for Non-Hodgkin Lymphoma in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia
B-Cell Chronic Lymphocytic Leukemia
Lymphoid Leukemia
Mantle-Cell Lymphoma

Non-Hodgkin Lymphoma trials near Indianapolis, IN, USA:

A Dose Escalation and Cohort Expansion Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors or Non-Hodgkin Lymphoma

in participants with relapsed or refractory (R/R) solid tumors or non-Hodgkin lymphoma (NHL).Part 2: Cohort Expansion. The...

Enrolling
Non-Hodgkin Lymphoma
Relapsed Solid Tumors
Drug: KB-0742

Phase 1, Phase 2

Kronos Bio

Indianapolis, Indiana, United States and 25 other locations

This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of IMPT-314, a bispecific chimeric antigen receptor (CAR) targ...

Enrolling
Relapsed Non-Hodgkin Lymphoma
Refractory Non-Hodgkin Lymphoma
Drug: IMPT-314

Phase 1, Phase 2

ImmPACT Bio

Indianapolis, Indiana, United States of America and 19 other locations

Phase 1, open-label, multicenter study of WTX-330 administered as a monotherapy to patients with advanced or metastatic solid tumors or non- ...

Enrolling
Non-Hodgkin Lymphoma
Advanced or Metastatic Solid Tumors
Drug: WTX-330

Phase 1

Werewolf Therapeutics

Indianapolis, Indiana, United States and 8 other locations

Locations recently updated

participants with relapsed or refractory (R/R) diffuse-large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma, transformed folli...

Enrolling
Non-Hodgkin Lymphoma
Drug: Tocilizumab
Drug: Gemcitabine

Phase 3

Roche
Roche

Noblesville, Indiana, United States and 72 other locations

The purpose of this single-arm, open-label, Phase 1b/2a, multicenter basket study is to evaluate whether tafasitamab and parsaclisib can be safely co...

Active, not recruiting
Non Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Drug: tafasitamab
Drug: parsaclisib

Phase 1, Phase 2

Incyte
Incyte

Indianapolis, Indiana, United States and 49 other locations

is in comparison with the combination of rituximab and chemotherapy, the current standard of care treatment approved for Non-Hodgkin...

Enrolling
Diffuse Large B-cell Lymphoma (DLBCL)
Drug: Doxorubicin
Drug: Prednisone/Prednisolone

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Indianapolis, Indiana, United States and 75 other locations

is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL)....

Enrolling
Follicular Lymphoma (FL)
Drug: Odronextamab
Drug: Rituximab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Noblesville, Indiana, United States and 65 other locations

The purpose of this study is to determine the side effects of treatment of the combination of nivolumab and daratumumab in participants with relapsed...

Active, not recruiting
Hodgkin Lymphoma
Non-Hodgkin's Lymphoma
Biological: Nivolumab
Biological: Lirilumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Indianapolis, Indiana, United States and 42 other locations

is focused on participants with previously untreated follicular lymphoma in Part 2, as well as participants with lymphoma that has -...

Enrolling
Follicular Lymphoma (FL)
Drug: Odronextamab
Drug: Vincristine

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Noblesville, Indiana, United States and 34 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic-...

Enrolling
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

Indianapolis, Indiana, United States and 50 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems